173 related articles for article (PubMed ID: 3119936)
1. Therapy of mitochondrial disorders.
Przyrembel H
J Inherit Metab Dis; 1987; 10 Suppl 1():129-46. PubMed ID: 3119936
[TBL] [Abstract][Full Text] [Related]
2. Genetic disorders of carnitine metabolism and their nutritional management.
Kerner J; Hoppel C
Annu Rev Nutr; 1998; 18():179-206. PubMed ID: 9706223
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial myopathies.
DiMauro S; Bonilla E; Zeviani M; Servidei S; DeVivo DC; Schon EA
J Inherit Metab Dis; 1987; 10 Suppl 1():113-28. PubMed ID: 2824920
[TBL] [Abstract][Full Text] [Related]
4. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
[TBL] [Abstract][Full Text] [Related]
5. Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.
El-Gharbawy A; Vockley J
Pediatr Clin North Am; 2018 Apr; 65(2):317-335. PubMed ID: 29502916
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
Tune BM; Hsu CY
J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
[TBL] [Abstract][Full Text] [Related]
7. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle.
Knottnerus SJG; Bleeker JC; Wüst RCI; Ferdinandusse S; IJlst L; Wijburg FA; Wanders RJA; Visser G; Houtkooper RH
Rev Endocr Metab Disord; 2018 Mar; 19(1):93-106. PubMed ID: 29926323
[TBL] [Abstract][Full Text] [Related]
8. Inherited disorders of mitochondrial fatty acid oxidation.
Coates PM; Stanley CA
Prog Liver Dis; 1992; 10():123-38. PubMed ID: 1296227
[No Abstract] [Full Text] [Related]
9. Inherited defects of mitochondrial fatty acid oxidation.
Turnbull DM; Shepherd IM; Aynsley-Green A
Biochem Soc Trans; 1988 Jun; 16(3):424-7. PubMed ID: 3181618
[No Abstract] [Full Text] [Related]
10. Respiratory-chain and pyruvate metabolism defects: Italian collaborative survey on 72 patients.
Caruso U; Adami A; Bertini E; Burlina AB; Carnevale F; Cerone R; Dionisi-Vici C; Giordano G; Leuzzi E; Parenti G; Savasta S; Uziel G; Zeviani M
J Inherit Metab Dis; 1996; 19(2):143-8. PubMed ID: 8739951
[No Abstract] [Full Text] [Related]
11. Diagnosis and management of defects of mitochondrial beta-oxidation.
Vockley J; Singh RH; Whiteman DA
Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):601-9. PubMed ID: 12394635
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.
Chase JF; Tubbs PK
Biochem J; 1972 Aug; 129(1):55-65. PubMed ID: 4646779
[TBL] [Abstract][Full Text] [Related]
13. The effect of chronic alcohol administration on fatty acid metabolism and pyruvate oxidation of heart mitochondria.
Williams ES; Li TK
J Mol Cell Cardiol; 1977 Dec; 9(12):1003-11. PubMed ID: 563474
[No Abstract] [Full Text] [Related]
14. Beta-oxidation as channeled reaction linked to citric acid cycle: evidence from measurements of mitochondrial pyruvate oxidation during fatty acid degradation.
Förster ME; Staib W
Int J Biochem; 1992 Jul; 24(7):1111-6. PubMed ID: 1397504
[TBL] [Abstract][Full Text] [Related]
15. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroid state and membrane fatty acid composition influence cardiac mitochondrial pyruvate oxidation.
Pehowich DJ
Biochim Biophys Acta; 1995 May; 1235(2):231-8. PubMed ID: 7756330
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
18. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
19. Studies on the formation of lactate and pyruvate from glucose in cultured skin fibroblasts: implications for detection of respiratory chain defects.
Wijburg FA; Feller N; Scholte HR; Przyrembel H; Wanders RJ
Biochem Int; 1989 Sep; 19(3):563-70. PubMed ID: 2554914
[TBL] [Abstract][Full Text] [Related]
20. Impaired energy metabolism of the taurine‑deficient heart.
Schaffer SW; Shimada-Takaura K; Jong CJ; Ito T; Takahashi K
Amino Acids; 2016 Feb; 48(2):549-58. PubMed ID: 26475290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
